Zhang X, Hu C, Tian E, Shen Y, Liu W, Li J
Front Pharmacol. 2025; 15:1501407.
PMID: 39764460
PMC: 11700742.
DOI: 10.3389/fphar.2024.1501407.
Mayr G, Bublitz M, Steiert T, Loscher B, Wittig M, ElAbd H
Front Immunol. 2024; 15:1452637.
PMID: 39726599
PMC: 11669894.
DOI: 10.3389/fimmu.2024.1452637.
Bibika M, Kanellopoulos P, Rouchota M, Loudos G, Nock B, Krenning E
Pharmaceutics. 2024; 16(9).
PMID: 39339259
PMC: 11435135.
DOI: 10.3390/pharmaceutics16091223.
Zhang B, Gang Q, Meng L, Li Z, Chu X, Wu H
BMC Med Genomics. 2024; 17(1):223.
PMID: 39232784
PMC: 11373294.
DOI: 10.1186/s12920-024-01996-3.
Tiwari C, Khan H, Grewal A, Dhankhar S, Chauhan S, Dua K
Inflammopharmacology. 2024; 32(5):3037-3056.
PMID: 39164607
DOI: 10.1007/s10787-024-01526-8.
Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies.
Ling S, Lilyanna S, Ng J, Chong J, Lin Q, Yong X
Cell Mol Life Sci. 2024; 81(1):42.
PMID: 38217709
PMC: 10787894.
DOI: 10.1007/s00018-023-05083-1.
Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.
Kim E, Kim H, Jedrychowski M, Bakiasi G, Park J, Kruskop J
Neuron. 2023; 111(22):3619-3633.e8.
PMID: 37689059
PMC: 10840702.
DOI: 10.1016/j.neuron.2023.08.012.
Radiolabeled Bombesin Analogs.
Mansi R, Nock B, Dalm S, Busstra M, van Weerden W, Maina T
Cancers (Basel). 2021; 13(22).
PMID: 34830920
PMC: 8616220.
DOI: 10.3390/cancers13225766.
Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios.
Suzuki H, Kise S, Kaizuka Y, Watanabe R, Sugawa T, Furukawa T
ACS Omega. 2021; 6(33):21556-21562.
PMID: 34471758
PMC: 8388099.
DOI: 10.1021/acsomega.1c02516.
Selective Moonlighting Cell-Penetrating Peptides.
Moran-Torres R, Castillo Gonzalez D, Duran-Pasten M, Aguilar-Maldonado B, Castro-Obregon S, Del Rio G
Pharmaceutics. 2021; 13(8).
PMID: 34452080
PMC: 8400200.
DOI: 10.3390/pharmaceutics13081119.
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N, Lee H
Int J Mol Sci. 2021; 22(14).
PMID: 34299316
PMC: 8307724.
DOI: 10.3390/ijms22147697.
Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?.
Lupon J, Santiago-Vacas E, Cediel G, Codina P, Domingo M, Revuelta-Lopez E
PLoS One. 2021; 16(5):e0249674.
PMID: 33989294
PMC: 8121351.
DOI: 10.1371/journal.pone.0249674.
The Drosophila melanogaster Neprilysin Nepl15 is involved in lipid and carbohydrate storage.
Banerjee S, Woods C, Burnett M, Park S, Ja W, Curtiss J
Sci Rep. 2021; 11(1):2099.
PMID: 33483521
PMC: 7822871.
DOI: 10.1038/s41598-021-81165-z.
Structural analysis of Mycobacterium tuberculosis M13 metalloprotease Zmp1 open states.
Liang W, Mancl J, Zhao M, Tang W
Structure. 2020; 29(7):709-720.e3.
PMID: 33378640
PMC: 8691456.
DOI: 10.1016/j.str.2020.12.002.
CD10 Cells and IgM in Pathogen Response in Lumpfish () Eye Tissues.
Gendron R, Paradis H, Ahmad R, Kao K, Boyce D, Good W
Front Immunol. 2020; 11:576897.
PMID: 33329544
PMC: 7714965.
DOI: 10.3389/fimmu.2020.576897.
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [Tc]Tc-DB4 and [In]In-SG4 in Mice Treated with Entresto.
Kanellopoulos P, Kaloudi A, Rouchota M, Loudos G, de Jong M, Krenning E
Pharmaceutics. 2020; 12(12).
PMID: 33256013
PMC: 7760338.
DOI: 10.3390/pharmaceutics12121145.
Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease.
Kim N, Lee H
Biomed Res Int. 2020; 2020:2010728.
PMID: 33224974
PMC: 7669341.
DOI: 10.1155/2020/2010728.
Repurposing of existing FDA approved drugs for Neprilysin inhibition: An study.
Sankhe R, Rathi E, Manandhar S, Kumar A, Pai S, Kini S
J Mol Struct. 2020; 1224:129073.
PMID: 32834116
PMC: 7422802.
DOI: 10.1016/j.molstruc.2020.129073.
Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF.
Prausmuller S, Arfsten H, Spinka G, Freitag C, Bartko P, Goliasch G
J Am Heart Assoc. 2020; 9(11):e015071.
PMID: 32427034
PMC: 7428996.
DOI: 10.1161/JAHA.119.015071.
Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications-A systematic review.
Ramanathan K, Padmanabhan G
Indian Heart J. 2020; 72(1):14-19.
PMID: 32423555
PMC: 7231860.
DOI: 10.1016/j.ihj.2020.01.006.